MY187342A - Skin-protection composition containing dendrobium-based ingredients - Google Patents
Skin-protection composition containing dendrobium-based ingredientsInfo
- Publication number
- MY187342A MY187342A MYPI2019002612A MYPI2019002612A MY187342A MY 187342 A MY187342 A MY 187342A MY PI2019002612 A MYPI2019002612 A MY PI2019002612A MY PI2019002612 A MYPI2019002612 A MY PI2019002612A MY 187342 A MY187342 A MY 187342A
- Authority
- MY
- Malaysia
- Prior art keywords
- skin
- dendrobium
- relates
- ingredients
- protection
- Prior art date
Links
- 241001523681 Dendrobium Species 0.000 title abstract 5
- 239000004615 ingredient Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000003436 stilbenoids Chemical class 0.000 abstract 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract 2
- HITJFUSPLYBJPE-UHFFFAOYSA-N dihydroresveratrol Chemical compound C1=CC(O)=CC=C1CCC1=CC(O)=CC(O)=C1 HITJFUSPLYBJPE-UHFFFAOYSA-N 0.000 abstract 2
- 239000000284 extract Substances 0.000 abstract 2
- 240000004638 Dendrobium nobile Species 0.000 abstract 1
- 241001076416 Dendrobium tosaense Species 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 210000002752 melanocyte Anatomy 0.000 abstract 1
- 230000003061 melanogenesis Effects 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000003642 reactive oxygen metabolite Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- 230000009759 skin aging Effects 0.000 abstract 1
- 238000001308 synthesis method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
- C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/215—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring having unsaturation outside the six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/30—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with trihydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond
- C07C69/54—Acrylic acid esters; Methacrylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
- C07C69/614—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety of phenylacetic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to a skin-whitening and skin-protection composition that comprises stilbenoid(s) and/or stilbenoid-containing extract(s) obtained from Dendrobium plants, such as Dendrobium officinale and Dendrobium nobile for the management of melanogenesis, skin-darkening and skin-aging. More particularly, it relates to the usage of Dendrobium ingredients and stilbenoids to reduce the formation of melanin in melanocytes. It also relates to the usage of Dendrobium ingredients and stilbenoids to reduce the generation of reactive oxygen species and oxidative free radicals. This invention relates to the use of Dendrobium-derived extracts or ingredients or stilbenoids in the formulation of skin- protection, skin-whitening and/or anti-skin aging products. Compounds for use in preparation of a composition for treating, preventing, and/or delaying the progress of skin darkening or for use in skin-whitening and skin-protection which are synthesized from dihydro-resveratrol and the related synthesis method are also provided in the present invention.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/351,636 US9738581B2 (en) | 2015-06-16 | 2016-11-15 | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions |
| US15/352,903 US9956152B2 (en) | 2015-06-16 | 2016-11-16 | Skin-protection composition containing dendrobium-based ingredients |
| US15/633,780 US9877931B2 (en) | 2015-06-16 | 2017-06-27 | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions |
| PCT/CN2017/107798 WO2018090805A1 (en) | 2016-11-15 | 2017-10-26 | Skin-protection composition containing dendrobium-based ingredients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY187342A true MY187342A (en) | 2021-09-22 |
Family
ID=62145206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2019002612A MY187342A (en) | 2016-11-15 | 2017-10-26 | Skin-protection composition containing dendrobium-based ingredients |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP7051843B2 (en) |
| CN (1) | CN109952286B (en) |
| MY (1) | MY187342A (en) |
| TW (1) | TWI732967B (en) |
| WO (1) | WO2018090805A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115634187B (en) * | 2022-12-26 | 2023-03-31 | 云南英格生物技术有限公司 | Dendrobium officinale flower extract and its preparation method and application, dendrobium officinale flower extract and its application, soothing face cream and its preparation method |
| KR20260034675A (en) * | 2023-07-07 | 2026-03-11 | 칼리웨이 바이오파마슈티칼스 코., 엘티디. | Pharmaceutical composition for use in reducing hyperpigmentation |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2919180B1 (en) | 2007-07-25 | 2009-11-27 | Trophos | USE OF AT LEAST ONE OXIME CHOLEST-4-EN-3-ONE DERIVATIVE AS ANTIOXIDANTS |
| FR2923717B1 (en) | 2007-11-15 | 2015-01-16 | Caudalie | COMPOSITIONS OF STILBENIC POLYPHENOLIC DERIVATIVES AND THEIR APPLICATIONS FOR COMBATING PATHOLOGIES AND ENHANCING LIVING ORGANISMS |
| JP2009292768A (en) | 2008-06-05 | 2009-12-17 | National Institute Of Advanced Industrial & Technology | New compound and its production method using microorganism, and antioxidant comprising the same as effective ingredient |
| PL3542780T3 (en) * | 2008-07-21 | 2022-05-02 | Unigen, Inc. | A SERIES OF WHITENING (BRIGHTENING) COMPOUNDS |
| NZ594298A (en) * | 2009-01-29 | 2014-01-31 | Commw Scient Ind Res Org | Molecularly imprinted polymers |
| JP2011213716A (en) | 2010-03-15 | 2011-10-27 | Mitsubishi Chemicals Corp | Method for producing polyallyloxy compound and method for producing polyglycidyloxy compound |
| CN102816090A (en) * | 2012-09-10 | 2012-12-12 | 四川大学 | Carbamate compounds, preparation method and application thereof |
| KR101480600B1 (en) * | 2013-01-22 | 2015-01-08 | 경북대학교 산학협력단 | A use for skin whitening of resveratrol derivatives |
| EP3085758B1 (en) | 2013-12-19 | 2018-06-06 | Kao Corporation | Perfuming method |
| JP6262569B2 (en) | 2014-03-03 | 2018-01-17 | 国立大学法人宇都宮大学 | Resveratrol derivative and tyrosinase activity inhibitor |
| JP6527347B2 (en) | 2014-03-27 | 2019-06-05 | 日光ケミカルズ株式会社 | Transparent to translucent cosmetics |
| US9526706B1 (en) * | 2015-06-16 | 2016-12-27 | Hong Kong Baptist University | Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury |
-
2017
- 2017-10-26 MY MYPI2019002612A patent/MY187342A/en unknown
- 2017-10-26 JP JP2019524017A patent/JP7051843B2/en active Active
- 2017-10-26 WO PCT/CN2017/107798 patent/WO2018090805A1/en not_active Ceased
- 2017-10-26 CN CN201780069402.9A patent/CN109952286B/en active Active
- 2017-11-07 TW TW106138517A patent/TWI732967B/en active
Also Published As
| Publication number | Publication date |
|---|---|
| CN109952286A (en) | 2019-06-28 |
| JP7051843B2 (en) | 2022-04-11 |
| CN109952286B (en) | 2022-03-22 |
| JP2020502050A (en) | 2020-01-23 |
| TWI732967B (en) | 2021-07-11 |
| WO2018090805A1 (en) | 2018-05-24 |
| TW201818956A (en) | 2018-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019501193A1 (en) | Use of chelating agents for improving color stability of resorcinol | |
| MY171285A (en) | Skin care compositions containing combinations of natural ingredients | |
| WO2019045259A3 (en) | Cosmetic composition including dendrobium candidum wallich ex lindley flower extract | |
| WO2019107753A3 (en) | Cosmetic composition for improving skin condition comprising mixture of brassica oleracea var. acephala seawater extract, nasturtium officinale seawater extract, and beta vulgaris root seawater extract | |
| PH12018500619B1 (en) | A skin lightening composition | |
| BR112013002216A2 (en) | "use of roasted coffee beans to regulate skin pigmentation" | |
| BR112013002215A2 (en) | use of green coffee beans to regulate skin pigmentation disorders | |
| BR112012032877A2 (en) | use of chicoric acid and derivatives for skin pigmentation regulation | |
| WO2014172568A3 (en) | Composition using botanicals and natural compounds for the promotion of healthy brain aging | |
| MY196718A (en) | Composition for skin whitening comprising b-mangostin as effective ingredient | |
| WO2011046978A3 (en) | Steroidal compounds as melanogenesis modifiers and uses thereof | |
| MX2014003449A (en) | Heterocyclocarbonylaminothiazoles, cosmetic or dermatological preparations containing said heterocyclocarbonylaminothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin. | |
| MY187342A (en) | Skin-protection composition containing dendrobium-based ingredients | |
| BR112013002326A2 (en) | use of a blend of roasted and green coffee beans to regulate skin pigmentation | |
| CL2019000375A1 (en) | Methods and compositions for reducing the graying of hair | |
| BR112012033090A2 (en) | use of kapharic acid and derivatives in food supplement for regulation of skin pigmentation | |
| MY171556A (en) | Method for inhibiting melanogenesis and promoting collagen production and wound healing | |
| MX341211B (en) | Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions. | |
| MX363850B (en) | Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a c1-c4 monoalkanol. | |
| WO2009134404A3 (en) | Steroidal compounds as melanogenesis modifiers and uses thereof | |
| TW201129394A (en) | Composition for inhibiting melanogenesis and use thereof | |
| MX2019005818A (en) | Cosmetic preparation having enhanced viscosity for treating keratinic fibres, method for increasing the viscosity of a cosmetic preparation, use of viscosity-modifying ingredients and method for treating keratinic fibres. | |
| MX391147B (en) | Composition for modulating the genes responsible for general skin functions, method for modulating the expression of genes responsible for general skin functions, and use of a plant extract | |
| EA201791493A1 (en) | COMPOSITION FOR BLEACHING OF THE SKIN, CONTAINING NIACINAMIDE AND ILOMASTAT | |
| MX2009012714A (en) | Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology. |